Herring Bradley — SEC Form 4 filings
SEC reporting owner CIK 1813901. 11 Form 4 filings on record with FilingPulse; latest filed 2026-05-28.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-10 to 2026-05-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 5 filings — 38,843 shares, $408,802 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 24,443 shares @ $10.61 ($259,340) in Enfusion, Inc., filed 2024-12-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Enfusion, Inc. (ENFN) | Chief Financial Officer | 8 | — | 6 legs · 38,843 sh · $408,802 | 7 |
| OPENLANE, Inc. (KAR) | EVP & CFO | 3 | — | — | 5 |
Form 4 filings — Herring Bradley
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-28 | 4 | OPENLANE, Inc. (KAR) | Option exercise (M): 16,190 @ $0 · Tax withholding (F): 4,453 @ $36.90 · Option exercise (M): 16,190 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | OPENLANE, Inc. (KAR) | Grant/award (A): 42,721 (derivative) @ $0 | EDGAR |
| 2025-05-28 | 4 | OPENLANE, Inc. (KAR) | Grant/award (A): 48,572 (derivative) @ $0 | EDGAR |
| 2025-04-21 | 4 | Enfusion, Inc. (ENFN) | Disposition to issuer (D): 108,332 · Disposition to issuer (D): 216,357 | EDGAR |
| 2025-03-07 | 4 | Enfusion, Inc. (ENFN) | Sale (S): 4,645 @ $11.38 | EDGAR |
| 2025-03-05 | 4 | Enfusion, Inc. (ENFN) | Sale (S): 1,533 @ $11.48 | EDGAR |
| 2025-02-28 | 4 | Enfusion, Inc. (ENFN) | Grant/award (A): 58,202 @ $0 · Grant/award (A): 6,296 @ $0 | EDGAR |
| 2025-01-10 | 4 | Enfusion, Inc. (ENFN) | Sale (S): 4,134 @ $10.13 | EDGAR |
| 2024-12-26 | 4 | Enfusion, Inc. (ENFN) | Sale (S): 24,443 @ $10.61 | EDGAR |
| 2024-03-05 | 4 | Enfusion, Inc. (ENFN) | Grant/award (A): 76,125 @ $0 · Grant/award (A): 9,546 @ $8.67 · Tax withholding (F): 2,325 @ $8.67 | EDGAR |
| 2024-01-10 | 4 | Enfusion, Inc. (ENFN) | Sale (S): 1,998 @ $9.23 · Sale (S): 2,090 @ $8.95 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-10 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1813901 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →